Assistant Professor of Medicine
University of North Carolina
Dr. Andermann is an Assistant Professor of Medicine in the Division of Immunocompromised Host Infectious Diseases at UNC Chapel Hill. She moved here to North Carolina almost 4 years ago from the Bay Area in California where she did all of her medical training including a Transplant Infectious Diseases fellowship at Stanford. During her fellowship, she spent 4 years in the lab of Dr. Ami Bhatt investigating the impact of gut microbiota-host interactions on cancer outcomes.
The Andermann Lab integrates short-read shotgun metagenomic and long-read Nanopore sequencing to investigate the antimicrobial gut “resistome” and AMR-specific horizontal gene transfer events in the gut under antibiotic and chemo/immunotherapy pressure. We aim to determine how antimicrobial resistance gene dynamics predict the risk of infectious complications of immune-suppressive therapy in patients with cancer. Dr. Andermann is also involved in multiple clinical projects on infectious outcomes following cellular immunotherapy treatment for hematologic malignancy.